$3.03 Million is the total value of Camber Capital Management LP's 40 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 21.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $251,460 | -17.2% | 2,000,000 | +3.9% | 8.29% | -16.2% |
| PFE | New | PFIZER INCcall | $248,775 | – | 7,500,000 | +100.0% | 8.20% | – |
| THC | Buy | TENET HEALTHCARE CORP | $240,499 | -7.6% | 3,650,000 | +14.1% | 7.93% | -6.5% |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $207,607 | +35.8% | 1,850,000 | +76.2% | 6.84% | +37.5% |
| VTRS | Sell | VIATRIS INC | $197,200 | -12.2% | 20,000,000 | -11.1% | 6.50% | -11.1% |
| SNY | Sell | SANOFIsponsored adr | $147,510 | -31.6% | 2,750,000 | -31.2% | 4.86% | -30.8% |
| MDT | Buy | MEDTRONIC PLC | $117,540 | +122.4% | 1,500,000 | +150.0% | 3.87% | +125.1% |
| WBA | Sell | WALGREENS BOOTS ALLIANCE INC | $115,648 | -45.9% | 5,200,000 | -30.7% | 3.81% | -45.2% |
| BAX | BAXTER INTL INC | $113,220 | -17.2% | 3,000,000 | 0.0% | 3.73% | -16.2% | |
| MYGN | MYRIAD GENETICS INC | $106,425 | -30.8% | 6,635,000 | 0.0% | 3.51% | -30.0% | |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $103,530 | +61.8% | 10,150,000 | +19.4% | 3.41% | +63.8% |
| Sell | GSK PLCsponsored adr | $103,313 | -29.3% | 2,850,000 | -30.5% | 3.40% | -28.4% | |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $102,060 | -0.5% | 2,250,000 | -10.0% | 3.36% | +0.7% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $96,976 | +111.7% | 800,000 | +100.0% | 3.20% | +114.2% |
| SEM | Sell | SELECT MED HLDGS CORP | $85,918 | -33.4% | 3,400,000 | -16.0% | 2.83% | -32.6% |
| GMED | Buy | GLOBUS MED INCcl a | $85,646 | +43.8% | 1,725,000 | +72.5% | 2.82% | +45.6% |
| PTCT | Buy | PTC THERAPEUTICS INC | $76,194 | -25.1% | 3,400,000 | +36.0% | 2.51% | -24.2% |
| BKD | BROOKDALE SR LIVING INC | $74,520 | -1.9% | 18,000,000 | 0.0% | 2.46% | -0.7% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $65,340 | +0.5% | 1,500,000 | -16.7% | 2.15% | +1.7% |
| XRAY | DENTSPLY SIRONA INC | $60,292 | -14.6% | 1,765,000 | 0.0% | 1.99% | -13.6% | |
| PRGO | Sell | PERRIGO CO PLC | $59,108 | -30.4% | 1,850,000 | -26.0% | 1.95% | -29.5% |
| HLF | Buy | HERBALIFE LTD | $39,872 | +9.5% | 2,850,000 | +3.6% | 1.31% | +10.8% |
| QTRX | Sell | QUANTERIX CORP | $34,604 | -55.2% | 1,275,000 | -62.8% | 1.14% | -54.6% |
| REPL | Buy | REPLIMUNE GROUP INC | $34,220 | -4.9% | 2,000,000 | +29.0% | 1.13% | -3.8% |
| ZIMVIE INC | $30,583 | -16.2% | 3,250,000 | 0.0% | 1.01% | -15.2% | ||
| SKIN | Buy | THE BEAUTY HEALTH COMPANY | $30,100 | +105.5% | 5,000,000 | +185.7% | 0.99% | +108.0% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $26,544 | – | 300,000 | +100.0% | 0.88% | – |
| OSUR | ORASURE TECHNOLOGIES INC | $25,203 | +18.4% | 4,250,000 | 0.0% | 0.83% | +19.9% | |
| New | QUIDELORTHO CORP | $23,738 | – | 325,000 | +100.0% | 0.78% | – | |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $23,468 | +4.0% | 1,050,000 | 0.0% | 0.77% | +5.3% | |
| PTON | Buy | PELOTON INTERACTIVE INC | $22,725 | -1.5% | 4,500,000 | +50.0% | 0.75% | -0.3% |
| QGEN | New | QIAGEN NV | $16,200 | – | 400,000 | +100.0% | 0.53% | – |
| BROOKDALE SR LIVING INCunit 11/15/2025 | $15,079 | -2.7% | 250,000 | 0.0% | 0.50% | -1.6% | ||
| CVAC | Buy | CUREVAC N V | $11,953 | -21.6% | 1,750,000 | +19.7% | 0.39% | -20.6% |
| PBYI | PUMA BIOTECHNOLOGY INC | $11,138 | -25.5% | 4,235,000 | 0.0% | 0.37% | -24.6% | |
| INGN | Buy | INOGEN INC | $10,440 | -21.4% | 2,000,000 | +73.9% | 0.34% | -20.6% |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $8,036 | – | 400,000 | +100.0% | 0.26% | – |
| EXEL | Sell | EXELIXIS INC | $6,555 | -77.9% | 300,000 | -80.6% | 0.22% | -77.6% |
| SOLID BIOSCIENCES INC | $3,574 | -51.9% | 1,418,439 | 0.0% | 0.12% | -51.2% | ||
| CANO | CANO HEALTH INC | $1,014 | -81.8% | 4,000,000 | 0.0% | 0.03% | -81.8% | |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -300,000 | -100.0% | -0.13% | – |
| GKOS | Exit | GLAUKOS CORP | $0 | – | -160,000 | -100.0% | -0.37% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -400,000 | -100.0% | -0.88% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICALS INDS LTD | 34 | Q3 2023 | 9.7% |
| BROOKDALE SR LIVING INC | 32 | Q3 2023 | 5.0% |
| PERRIGO CO PLC | 29 | Q3 2023 | 7.1% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 8.5% |
| NEKTAR THERAPEUTICS | 28 | Q1 2022 | 9.8% |
| UNIVERSAL HLTH SVCS INC | 25 | Q3 2023 | 9.9% |
| MYRIAD GENETICS INC | 24 | Q3 2023 | 5.0% |
| SAREPTA THERAPEUTICS INC | 23 | Q3 2023 | 6.0% |
| MYLAN NV | 21 | Q3 2020 | 10.1% |
| AMAG PHARMACEUTICALS INC | 21 | Q3 2020 | 4.0% |
View Camber Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC | February 02, 2023 | ? | ? |
| Solid Biosciences Inc. | December 12, 2022 | ? | ? |
| AVROBIO, Inc. | February 14, 2022 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2022 | ? | ? |
| AMAG PHARMACEUTICALS, INC. | February 16, 2021 | ? | ? |
| Atara Biotherapeutics, Inc. | February 16, 2021 | ? | ? |
| Change Healthcare Inc. | February 16, 2021 | ? | ? |
| GLYCOMIMETICS INC | February 16, 2021 | ? | ? |
| Clovis Oncology, Inc. | February 14, 2020 | ? | ? |
| Cyclerion Therapeutics, Inc. | February 14, 2020 | ? | ? |
View Camber Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-30 |
| 13F-HR | 2023-08-14 |
View Camber Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.